Cost-effectiveness of HIV Monitoring Strategies in Resource-Limited Settings
Open Access
- 22 September 2008
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 168 (17), 1910-1918
- https://doi.org/10.1001/archinternmed.2008.1
Abstract
Two-thirds of the world's HIV-infected population resides in Africa, and most of the world's new infections occur in low- and middle-income countries. In the southern cone of Africa, which includes heavily affected countries such as Angola, Botswana, Malawi, Mozambique, Namibia, South Africa, Zambia, and Zimbabwe, approximately 11 million persons are infected with HIV.1,2 Despite substantial progress in access to treatment, only 20% of adults who need highly active antiretroviral therapy (HAART) receive it.1 In addition, in many resource-limited regions, the conditions of individuals who receive HAART are managed without access to monitoring of CD4 T-cell counts or human immunodeficiency viral load, which may substantially reduce the effectiveness of HAART.3 Therefore, key questions in the management of HIV infection in resource-constrained settings are whether and how to monitor persons infected with HIV and when to initiate HAART. Little is known about the effectiveness and cost-effectiveness of evaluation and treatment initiation criteria in southern Africa, and monitoring of infected individuals remains a major challenge for clinicians and health care systems.4,5Keywords
This publication has 28 references indexed in Scilit:
- The cost effectiveness of antiretroviral treatment strategies in resource-limited settingsAIDS, 2007
- Conservation of First-Line Antiretroviral Treatment Regimen where Therapeutic Options are LimitedAntiviral Therapy, 2007
- Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal studyThe Lancet, 2006
- CD4 Decline and Incidence of Opportunistic Infections in Cape Town, South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in AfricaAIDS, 2006
- Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited settingJournal of Translational Medicine, 2006
- Immunological recovery and antiretroviral therapy in HIV-1 infectionThe Lancet Infectious Diseases, 2006
- Initiating highly active antiretroviral therapy in sub-Saharan AfricaAIDS, 2004
- Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 InfectionThe New England Journal of Medicine, 2003
- Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort studyThe Lancet, 2002